Role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients

Age Ageing. 1993 Jul;22(4):256-9. doi: 10.1093/ageing/22.4.256.

Abstract

Fifteen elderly patients with type B gastritis caused by Helicobacter pylori infection were treated with triple therapy consisting of colloidal bismuth subcitrate, amoxycillin and metronidazole. All were followed up every 6 weeks for 3 months. After triple therapy, eradication of the infection was confirmed in 12 patients (85%) by histology and bacteriology. In this group, a significant reduction in IgG antibody levels against H. pylori was detected (p < 0.001). In a control group of 15 patients with type B gastritis who received no antibacterial treatment, the specific IgG antibody titre remained unchanged during 3 months of follow-up. We conclude that this simple and noninvasive serological test would be suitable for follow-up after treatment of H. pylori infection in elderly patients.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amoxicillin / administration & dosage*
  • Anti-Bacterial Agents / administration & dosage*
  • Antibodies, Bacterial / analysis*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Gastroscopy
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / immunology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / immunology
  • Humans
  • Immunoglobulin G / analysis*
  • Male
  • Metronidazole / administration & dosage*
  • Organometallic Compounds / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Immunoglobulin G
  • Organometallic Compounds
  • Metronidazole
  • Amoxicillin
  • bismuth tripotassium dicitrate